Medtech Commercialization
Commercialization is where most medtech companies lose their runway. We build the full path from cleared product to repeatable revenue, and stay through the first cycle to make sure it holds.
The commercialization gap
Regulatory clearance proves the device is safe and effective. It proves nothing about whether a hospital will buy it, at what price, through which contract, or who inside the building has to agree. That gap is where funded companies stall.
What we build
A launch plan with owners, sequence, and the economics behind each step.
- Beachhead market selection and account targeting
- Reimbursement and coding narrative, or the self-pay and capital case where coverage is absent
- Channel decision: direct, distributor, GPO and IDN, or hybrid
- Pricing and contract structures that clear procurement
- Sales motion, hiring plan, training, and forecast cadence
How we stay accountable
We work against your live pipeline, not a hypothetical one. Every element of the plan is tested in a real account before it is documented as the standard motion.
Why it matters
A cleared device sitting in a warehouse helps no one. Commercialization is the step that turns approved technology into treated patients.
Common questions
When should we start commercialization work?
Ideally six to twelve months before clearance, so market selection and reimbursement work is underway when you are free to sell.
Do you support international launch?
Our core work is US commercialization; we scope international case by case.
Can you supply the commercial team?
Yes. We place trained sellers and business development affiliates while your permanent team is built.
Cleared product, no commercial engine?
Start with a brief 15-minute discovery call to discuss your project and confirm fit. Qualified leads are invited to a private technical session for an in-depth look at your scientific challenge.
Discuss Your Project